| Abstract: | Combination antiretroviral therapy (ART) reduced AIDS-related mortality and increased survival among patients living with HIV by interrupting HIV replication, enhancing immune recovery, and preventing the onset of opportunistic infections1].?In?China,?ART?has?rapidly?been?scaled?up since the beginning of the National Free Antiretroviral?Treatment?Program?(NFATP)?in?20032]. By the end of 2016, 489,411 individuals diagnosed with?HIV?were?receiving?free?antiretroviral?treatment in China. China is firmly committed to reducing overall AIDS-related mortality and HIV incidence within the country. However, similar to other low-and middle-income countries, the NFATP is challenged by high mortality and attrition shortly after?patients?initiate?ART3]. |
